NetworkNewsBreaks Archive - Page 2175 of 2304

WednesdayAug 23, 2017 1:55 pm

NetworkNewsBreaks – Tandem Diabetes Care, Inc. (NASDAQ: TNDM) Sets Launch of t:lock™ Connector for its Insulin Pump Cartridges and Infusion Sets

Tandem Diabetes Care (NASDAQ: TNDM) this morning said it is preparing to launch its t:lock™ connector for its insulin pump cartridges and infusion sets, with the gradual rollout set to begin September 5. Additionally, all infusion sets currently offered by Tandem will be made available with the new t:lock connector and the company expects to fully transition by the end of 2017. The t:lock versions of Tandem’s current infusion sets will be sold under the brand names AutoSoft™, VariSoft™ and TruSteel™. “This launch strengthens our overall insulin delivery systems, addressing one of our customers’ most frequent requests to make the…

WednesdayAug 23, 2017 12:34 pm

NetworkNewsBreaks – Celldex Therapeutics, Inc. (NASDAQ: CLDX) Completes Patient Enrollment in METRIC Study

Celldex Therapeutics (NASDAQ: CLDX) this morning said that it has completed patient enrollment in its phase 2b METRIC study of glembatumumab vedotin (glemba) in patients with metastatic triple negative breast cancers that overexpress gpNMB. The antibody-drug conjugate, glemba, works by targeting and binding to the protein expressed by multiple tumor types, gpNMB. The company expects that topline primary endpoint data will be reported in the second quarter of 2018. "Patients with triple negative breast cancer have very limited treatment options. We believe glemba holds significant promise as a potential new targeted treatment for patients with this devastating disease and look…

WednesdayAug 23, 2017 12:32 pm

NetworkNewsBreaks – Novavax, Inc.’s (NASDAQ: NVAX) Preclinical NanoFlu™ Study Published in Vaccine

Shares of Novavax (NASDAQ: NVAX) are up 4% following the company’s news that data from a preclinical study have been published in the journal, ‘Vaccine.’ The preclinical study of the company’s influenza vaccine candidate with its proprietary Matrix-M™ adjuvant, NanoFlu™, suggests that NanoFlu has the potential to provide a stronger immune response than influenza vaccines currently available to older adults. “The data in this publication further validate our nanoparticle vaccine platform and provide a strong rationale for advancing NanoFlu into a Phase 1/2 clinical trial. Our goal is to deliver a superior, differentiated vaccine to the greater than $3 billion…

WednesdayAug 23, 2017 9:17 am

NetworkNewsBreaks – PotNetwork Holdings, Inc. (POTN) Adds Dr. David Feldbaum to Newly Formed Advisory Board

PotNetwork Holdings, Inc. (OTC: POTN) this morning announced the addition of Dr. David M. Feldbaum MD, FACS to its board of advisors. Feldbaum is certified in vascular surgery by the American Board of Surgery, having completed a surgical residency at Montefiore Medical Center/Albert Einstein College of Medicine in New York City. “We are very pleased to have Dr. Feldbaum join our growing team of advisors,” Maria Gomez, regional vice president of sales for PotNetwork subsidiary Diamond CBD, stated in the news release. “We expect that his experience and wisdom will strengthen the Company’s position in the industry as we target…

TuesdayAug 22, 2017 12:09 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on August 22, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ZYXI 22.31% – News: Receives coverage by Taglich Brothers, Inc BDIC 18.79% – News: Posts Q2 2017 financial results FTNW 9.92% – News: Posts Q2 2017 financial results MTBC 7.14% – News: Secures revenue cycle management vendor contract with Infinity Diagnostic Labs GOPH 6.96% – News: Launching presale campaign on August 29 for pet tracking device APWC 6.79% – News: Posts first half 2017 financial results; hosting shareholders meeting on October 20 CLRB 6.08%…

TuesdayAug 22, 2017 12:06 pm

NetworkNewsBreaks – Inpixon (NASDAQ: INPX) Enters New Partnership with GTRI to Boost Physical Cybersecurity Line; Shares Weighted by Q2 Results

Inpixon (NASDAQ: INPX) this morning said it has entered into a partnership with GTRI, an IT consulting and services company, to render comprehensive three-dimensional physical cybersecurity solutions, including Inpixon Indoor Positioning Analytics (IPA) Security Dome. Per the agreement, GTRI will leverage the company’s technology to enable government organizations and enterprises to identify any potential exposures while preserving security and compliance standards. Shares of Inpixon are down 14% mid-day, likely moving on the company’s second-quarter financial performance, reported yesterday. Revenues increased $1.8 million to $15.1 million, compared to the second quarter of last year; Inpixon’s non-GAAP net loss widened to ($1.89)…

TuesdayAug 22, 2017 12:03 pm

NetworkNewsBreaks – SeeThruEquity Updates Coverage on Innovus Pharmaceuticals, Inc. (INNV)

SeeThruEquity has updated its coverage and maintained its price target of $0.65 on shares of Innovus Pharmaceuticals, Inc.’s (OTCQB: INNV) stock following the company’s report of financial results for the second quarter of 2017. Revenues of $2 million were reported for the quarter, a 99% increase over the second quarter of 2016. The company also confirmed that the commercial launch of FlutiCare™ is set for the fourth quarter of 2017. For more information, visit www.innovuspharma.com About Innovus Pharmaceuticals, Inc. Headquartered in San Diego, Innovus Pharma is an emerging over-the-counter (“OTC”) consumer goods and specialty pharmaceutical company engaged in the commercialization,…

TuesdayAug 22, 2017 9:42 am

NetworkNewsBreaks – HighCom Global Security, Inc. (HCGS) Provides Update on Key Corporate Milestones

Leading security solutions provider HighCom Global Security, Inc. (OTC: HCGS) this morning offered an update on key milestones the company has achieved in its product technology this year. These include the February launch of four new hard armor models through its HighCom Armor Solutions, Inc. division and the July NIJ approval of two additional armor models, including a Level IIIa elite, lightweight, high-performance soft armor panel and a Level III++, multi-curve, hard armor ballistic plate. “The addition of these new products increases HighCom Armor's ability to equip our customers with high quality, in demand armor that has been the cornerstone…

TuesdayAug 22, 2017 9:18 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Enters Letter of Intent to Acquire Dr. FeelGood

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that it has signed a letter of intent to acquire Dr. FeelGood, a profitable Phoenix-based medical marijuana company with plans to develop a proprietary delivery and ordering technology. Per the terms of the agreement, SinglePoint will acquire 51 percent of Dr. FeelGood through a combination of cash and stock, adding an additional revenue stream to SinglePoint while solidifying its acquisition-based revenue strategy. “This acquisition is right in our wheel house,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “I previously took a distribution company public on the NASDAQ…

MondayAug 21, 2017 4:09 pm

NetworkNewsBreaks – Cardiome Pharma Corp. (NASDAQ: CRME) Shares Sink on Disappointing Regulatory Feedback

Shares of Cardiome Pharma Corp. (NASDAQ: CRME) are down 33% near market close, though pulling from a new 52-week low reached earlier in the day’s trading session. Cardiome this morning said the U.S. FDA has advised that the company’s proposed data package would not would not be sufficient to support a resubmission of the BRINAVESS New Drug Application (NDA). BRINAVESS is Cardiome’s antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation (AF). “In our most recent communication with the FDA, we proposed resubmission of the NDA based upon the original file and six years of accumulated safety data…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks